Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
EXEL | EXELIXIS, INC. | Director | $292K | -$576K | -66.4% | Aug 13, 2024 |
STOK | Stoke Therapeutics, Inc. | Director | Jun 5, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|